Location History:
- Monksland, IE (1991)
- Gainesville, GA (US) (1993 - 1997)
- Athlone, IE (1990 - 2023)
Company Filing History:
12 out of 67 
1 out of 2 
1 out of 160 Years Active: 1990-2023
Title: Seamus Mulligan - A Pioneer in Pharmaceutical Innovations
Introduction
Seamus Mulligan, an accomplished inventor based in Athlone, Ireland, has made significant strides in the field of pharmaceuticals. With a remarkable portfolio of 15 patents, his work focuses primarily on innovative compositions aimed at enhancing treatment efficacy for various neurological diseases.
Latest Patents
Among his latest patents is the "Sustained Release Aminopyridine Composition," which describes a pharmaceutical composition comprising a therapeutically effective amount of aminopyridine dispersed in a release matrix. This formulation is designed for stable, sustained-release oral dosage, such as a tablet that delivers a therapeutically effective plasma level of the aminopyridine for at least 12 hours, and preferably up to 24 hours or more. This breakthrough has important implications for treating various neurological conditions.
Another notable patent is "Pharmaceutical Formulations for Preventing Drug Tolerance", which discloses isosorbide mononitrate formulations and methods that allow for subtherapeutic levels during washout periods. This innovation plays a crucial role in preventing nitrate tolerance in patients, thereby improving treatment outcomes.
Career Highlights
Throughout his career, Seamus Mulligan has been associated with prominent companies, including Elan Corporation, Plc. His expertise and innovative thinking have significantly contributed to the advancement of pharmaceutical sciences.
Collaborations
Mulligan has collaborated with renowned professionals in the industry, notably Edward J. Geoghegan and Donald E. Panoz. These collaborations have fostered an environment of creativity and knowledge sharing, leading to impactful advancements in pharmaceutical technologies.
Conclusion
Seamus Mulligan stands out as a notable inventor whose contributions to the pharmaceutical industry continue to shape the landscape of neurological treatments. His patents not only exemplify his innovative spirit but also hold the potential to improve the quality of life for many patients dealing with challenging medical conditions.